Automated Analysis of High-Throughput Protein Stability For Antibody Developability Assessment
End-to-End Sample Management Solution
Enhancing Gene Therapy Assets with GMP-Ready NGS Assays
Workflow Automation for High-Throughput Spectral Shift Analysis
NGS-Powered CMC Strategies
Biotherapeutics Development with NGS Assays In-House
HT-MS Analytics for ML/AI-Ready Drug Discovery
Turning Data into Decisions: RAS Inhibitor Case Study
Untargeted HILIC Metabolomics of Soybean Amino Acid Pathways
Robust and Versatile New Peak Detection for MAM Implementation
Boosting Efficiency in High-Throughput Intact Mass Spectrometry
Automated Workflow for Oligonucleotide Mass Mapping
Automated Peptide Mapping for Higher Throughput
Integrated Assay Analysis for Antibody Developability
Digital Platform for the Development of Next-Generation ADCs
Automated HT-Engineering Platform for AI-Supported Developability Predictions
Accelerating Biopharmaceutical and Vaccine Research, Discovery, and Development
NGS for CMC of Gene and Cell Therapy Products
Long-Read NGS for QC in CGTs Manufacturing
Do's and Don'ts of CSV for In-House NGS-Based Biosafety Assays
Platform for Streamlined LC/MS-based MAM Implementation
MS Analytics Platform for Emerging Therapeutic Modalities
Scalable, Automated Data Analysis Across RNA Therapeutics Assays
Data Integration Platform for Bioassays in Preclinical & Clinical Studies
Identification of Scrambled Disulfide Bonds in Biotherapeutics
GMP-Compliant NGS for Biotherapeutics Development
HT Screening for Best Manufacturing Cell Lines Using Scale-Down Models
Affinity-Based Screening Using HT Spectral Shift
Automated HT Multiplexed Intact Covalent Binding Data Analysis Workflow
Next Generation Trait Development and Crop Protection
End-to-End Assay Automation
SPR Evaluation of Large Bispecific Antibody Panels
Manage Developability & Manufacturability Risks of Biologics Molecules
AI-Based Segmentation for Single Cell Profiling
Automated Production of Viral Vectors for Cell and Gene Therapy
Genedata Selector: GMP Compliance for Safe Gene Therapy Development
ADC Therapeutics’ New ADC Workflow System
Comprehensive Antibody Discovery Screening with NGS
AI-based Denoising of LC-MS Data via Generative Adversarial Networks
MS-Based Characterization of Adeno-associated Virus Capsids
